Clinical Trials Directory

Trials / Completed

CompletedNCT05357131

Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis.

Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis (VRH) and Hypnosis (HYP) in a Healthy Participants.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
68 (actual)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Hypnosis and virtual reality are potential tools in treating acute pain. Nevertheless, the neurophysiological correlates of such tools used together, i.e. 'virtual reality hypnosis' (VRH) (Patterson et al., 2004) remain mostly understudied. This study aims to improve our knowledge and understanding of the dissociation (i.e., a mental separation of components of behaviours that normally would be processed together) occurring during VRH. This is a randomized controlled study that will be conducted on healthy participants. As the final goal is to propose such a tool in the clinical context, a clinical application will also be carried out subsequently. Thus the principal outcome is to study dissociation in the context of VRH from a behavioral and neurophysiological point of view. Secondary objectives aim at identifying factors that influence the dissociative effect seen in VRH, as well as measuring traits of hypnotisability, absorption, immersive abilities, dissociation trait and state, pain, and anxiety levels that might impact the effectiveness of such a tool.

Detailed description

The protocol will follow the following steps: 1. Before the experiment: * A medical screening of the medical history and of any concomitant medications will be performed to eligibility. * The 6-item Elkins Hypnotisability Scale (EHS) will be used to assess participant hypnotisability. * Questionnaire sur la Propension à l'Immersion (QPI) will be used to assess participant immersion tendency. 2. Experimental session: Cross-over and within-participant control design i. Visual Analogue Scale (VAS) : * Anxiety. * Pain. ii. EEG Resting-state (5-Min.). iii. EEG VRH or EEG Hypnosis alone (HYP) (15-Min.). iv. Adverse Events (AE) during the protocol will be recorded. v. Narrative recording. vi. VAS : * Dissociation * Absorption * Pain * Anxiety * Arousal/wakefulness * Automaticity vii. Time perception (open question) viii. CyberSickness (CSQ) (only if VRH) ix. Presence Questionnaire x. Satisfaction questionnaire xi. Washout Phase (30-Min.) during which we will administer : * Six-item State-Trait Anxiety Inventory (STAI-6) . * Tellegen Absorption Scale . * Dissociative Experience Scales (DES) . xii. VAS: * Anxiety * Pain xiv. Adverse Events during the protocol will be recorded. xv. Narrative recording. xvi. EEG HYP or EEG VRH Phase (15-Min.). xvii. VAS: * Dissociation * Absorption * Pain * Anxiety * Arousal/wakefulness * Time perception xviii. CSQ (only if VRH) xix. Presence Questionnaire. xx. Satisfaction Questionnaire .

Conditions

Interventions

TypeNameDescription
BEHAVIORALHypnosis without VR (HYP)HYP will last for 15 minutes including an induction phase of 5 minutes. The hypnotic audio script "Heaven of Peace" developped/recorded by Pr. M-E. Faymonville will be used.
DEVICEHypnosis with VR (VRH)The VRH intervention will use the Aqua video session developed by Oncomfort.

Timeline

Start date
2022-06-08
Primary completion
2023-06-14
Completion
2023-06-14
First posted
2022-05-02
Last updated
2023-07-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05357131. Inclusion in this directory is not an endorsement.